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A set of 28 racemic dihydrofurocoumarins and 13 dihydrofuroflavones in which the
stereogenic center is located in the furan ring have been synthesized. Currently no effective
asymmetric synthesis for these classes of compounds exists, although they are produced
naturally by many plant species. Their diverse medicinal properties are being investigated in
several laboratories. The enantioselective separation of these compounds by three native and
six derivatized cyclodextrins has been evaluated in the reversed phase mode, the polar
organic mode, and normal phase mode. Overall,20 of the 28 dihydrofurocoumarin and 9 of
the 13 dihydrofuroflavone analytes were baseline resolved (Rs > 1.5) on at least one of the
cyclodextrin-based chiral stationary phases. The hydroxypropyl-p-cyclodextrin (Cyclobond I
RSP) is the most effective chiral stationary phase (CSP) for the enantioseparations of these
compounds; baseline resolving 16 and 7 of the dihydrofurocoumarin and dihydrofuroflavone
analytes respectively. The 2,3-dimethyl-B-cyclodextrin (Cyclobond I DM) also performed
well, separating 18 dihydrofurocoumarin and 5 dihydrofuroflavone samples respectively.
The acetyl-B-cyclodextrin (Cyclobond I AC) baseline resolved 18 of the
dihydrofurocoumarin samples, however, no dihydrofuroflavones were separated on this CSP.
The aromatic derivatized p-cyclodextrins are only marginally effective at separating the
enantiomers of these compounds in the reversed phase mode. The native cyclodextrins
showed no enantioselectivity for either class of compound in the reversed phase mode. The
polar organic mode and the normal phase mode have also been evaluated with these CSPs,
but no enantioseparations were observed.
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INTRODUCTION
In the search for medicinally important compounds, scientists have discovered several
new classes of compounds. Of these, the dihydrofurocoumarin (Figure 1) and
dihydrofuroflavone (Figure 2) derivatives have shown a great deal of promise as potential
drug candidates. Both substituted dihydrofurocoumarins and substituted dihydrofuroflavones
have been found in several plant species [1-11].
Both of these classes of compounds exhibit a variety of important biological effects.
For dihydrofurocoumarins, the most significant of these properties are their photosensitizing
and mutagenic activities [12-20], especially their ability to halt DNA replication by forming
adducts with DNA nucleotides [17,18]. Dihydrofuroflavones are most useful for their
antioxidant properties l2l-301, particularly, their ability to inhibit the oxidative damage of
DNA [22].
It is well know that the biological activity of each enantiomer of a chiral compound
can vary greatly. Consequently, it has become standard practice to assess the biological
activity of each enantiomer of a chiral molecule and market new products as single isomers
[31]. To date, there has been no investigation of the biological activity of the individual
enantiomers of chiral dihydrofuroflavones and very little investigation into the biological
activity of chiral dihydrofurocoumarins 12,327. Additionally, the development of asymmetric
syntheses for these classes of compounds has been limited [33, 34]. Similarly, there have
been no methods published in the literature pertaining to the enantioseparation of these
classes of compounds. As such, methods must be developed to obtain both enantiomers of
these compounds in their pure form and to determine the biological activity of each.
Recently, efforts by Rozhkov have generated chiral dihydrofurocoumarins [35] and
chiral dihydrofuroflavones [36] by the palladium-catalyzed annulation of 1,3-dienes by o-
iodo-umbelliferones and o-iodoacetoxyflavonoids respectively. Substituents on the
dihydrofuran portion of the heterocycle create a stereogenic center in the furan ring of each
(Fig. lc and?c).
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Cyclodextrin based chiral stationary phases (CSPs) have been shown to be broadly
applicable in their ability to separate enantiomers of a wide variety of compounds [37,38].
They are quite successful at resolving the enantiomers of chiral molecules with aromatic
substituents 139-44). Furthermore, it has been shown that cyclodextrins are useful in the
analysis of various coumarin analogous such as warfarin, coumachlor, coumafuryl,
phenprocou mon 142,45,461. Additionally, B-cyclodextrin CSPs have been successful in
resolving the enantiomers of several flavanone glycosides such as prunin, naringin,
neohesperidin, and narirutin [47]. Consequently, cyclodextrin-based CSPs are a natural
choice as CSPs for addressing the liquid chromatographic chiral separation of these types of
compounds. The aim of this study is to evaluate the enantioselectivity of native and
derivatized cyclodextrin based CSPs for these chiral dihydrofurocoumarins and chiral
dihydrofuroflavones in all liquid chromatographic modes.
Cyclodextrins
History
The first documented use of Cyclodextrintype molecules in a separation process was
in 1959 by Cramer and Dietsche who evaluated their effectiveness as a selective
cocrystalliziation agent for specific isomers of chiral compounds [48]. This technique,
despite being successful at resolving some enantiomers of chiral compounds, is considered
by many to be quite tedious and not universally applicable to chiral separations. kr 1980,
Armstrong used cyclodextrins as a chiral mobile phase additive in thin-layer chromatography
[49]. The earliest success of binding a cyclodextrin moiety to silica was reported by both
Fujimura and Kawaguchi in 1983 [50, 51]. These initial attempts, while successful at
resolving the isomers of several aromatic compounds, were never commercialized due to the
inherent instability of the linkage arm that bound the cyclodextrin selector to the silica
support. The first successful cyclodextrin based CSP was developed by Armstrong in 1983
[52] and commercialized by Advanced Separation Technologies later that same year. This
CSP overcame the limitations of predecessors by using a stable epoxide linkage to bind the
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cyclodextrin to the silica support. This CSP has been used in the enantioseparation of many
compounds such as amino acids [53], barbiturates [53], phenylacetic acid derivatives [53],
metallocene enantiomers [54], and many other chiral aromatic compounds [55].
Properties
Cyclodextrins are chiral molecules consisting of cyclic oligosaccharides possessing a
torodial shape (i.e., a hollow truncated cone) 156,57). These are produced either by the
digestion of starch by the bacteria Bacillus macerans or by the enzymatic action of
cyclodextrin transglycosylase. Cyclodextrins are produced in several sizes, but the most
useful of these are the o- , B- , and y- cyclodextrins which are composed of 6, 7, and 8
glucose units linked by a-1,4 bonds. The cavity sizes of these molecules are quite different.
The cavity of an cr-cyclodextrin can hold a molecule the size of a benzene ring, the B-
cyclodextrin can accommodate a napthylene size molecule, and the y-cyclodextrin can
complex with 3-ringed systems such as anthracene or phenanthrene.
Another important structural feature of cyclodextrin molecules is the nature of the
hyrdroxyl groups on the rims of the molecule. The large end or mouth of the cyclodextrin
molecule is lined with secondary 2- and 3- hydroxyl goups and the naffow end or base is
lined with primary 6- hydroxyls [58. 59]. These hydroxyls can facilitate chiral recognition
by hydrogen bonding with analyte molecules. Additionally, the spatial orientation of these
hydroxyl groups creates a hydrophobic interior cavity. The hydrophobic portion of analyte
molecules can complex with or "include" into this cavity which is thought to be a major
factor in the chiral recognition of molecules in aqueous solvents. The cyclodextrin's
hydroxyl groups are also used to attach them to a stationary phase support via a linkage
chain. Lastly, the cyclodextrin's hydroxyl groups can be functionalized with a variety of
moieties to alter its enantioselectivity.
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Types of Cyclodextrin-based CSPs
There are several types of commercialized cyclodextrin CSPs. These can be
subdivided into three major classes: native cyclodextrin CSPs, derivatized cyclodextrin
CSPs, and aromatic derivatized CSPs. Each of these classes possesses different
characteristics which are important to enantioseparations.
Native Cyclodextrins
The most popular and useful of the native cyclodextrins is based on the B-
cyclodextrin chiral selector. This selector has been shown to be suitable for the
enantioseparation of many chiral compounds 142,44,551. The cr-cyclodextrin and T-
cyclodextrin CSPs are not as widely applicable as the B-cyclodextrin CSPs are, however, the
a-cyclodextrin gave the only reported separation of monoterpene hydrocarbons such as ct-
and p-pinene [59].
Derivatized and Aromatic Derivatized Cyclodextrins
There are several types of commercialized derivatized and aromatic derivatized
cyclodextrin CSPs. All of these derivatives are based on the p-cyclodextrin chiral selector.
The derivatized cyclodextrins CSPs are the acetylated-B-cyclodextrin (Cyclobond I AC),
2,3-dimethylated-B-cyclodextrin (Cyclobond I DM), and the hydroxypropyl-B-cyclodextrin
(Cyclobond I RSP). The aromatic derivatized cyclodextrin CSPs include the
napthylethylcarbamolate-B-cyclodextrin (Cyclobond I RN and SN) and the
dimethylphenylcarbamate-B-cyclodextrin (Cyclobond I DMP). An overview of these CSPs
is presented in Table 1.
All of these derivative groups are such that the effective size of the cyclodextrin
cavity is expanded; allowing it to complex larger analyte molecules. Additionally, the
aromatic derivatized cyclodextrins are the oniy cyclodextrin based CSPs useful in the normal
phase mode [59].
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Mechanism of Chiral Recognition and Modes of Operation
For a chiral separation to occur there must be at least 3 differing yet simultaneous
interactions about the stereogenic center. The types of interactions which are conducive to
chiral recognition include n-ninteractions, steric interactions (repulsion), hydrophobic
interactions, hydrogen bonding, dipole stacking, and electrostatic interactions. As with any
separation method, it is possible to have interactions between the analyte and chiral selector
which are not conducive to chiral recognition [68]. It is also possible to have two
competitive interactions with opposite selectivities which may counteract any observed
enantioselectivity [68].
There are three distinct modes of operation for the chromatographic enantioresolution
of analytes on all cyclodextrin-based CSPs. These are the reversed phase mode, normal phase
mode, and polar organic mode of operation; each of which has a unique mechanism for
retention and chiral recognition. A summary of the properties of each mode is presented in
Table2.
Thesis Organization
This study will investigate the enantioresolving power of cyclodextrin based CSPs for
the separation of racemic mixtures of chiral dihydrofurocoumarins (Chapter One) and chiral
dihydrofuroflavones (Chapter Two). All pertinent separation factors such as mobile phase
compositiotr, pH, buffer identity, and ionic strength are also investigated.
Previously, warfarin, coumachlor, coumafuryl, phenprocoumon, which are
structurally related compounds to both dihydrofurocoumarins and dihydrofuroflavones, have
been separated on the Cyclobond I DM 140,721, Cyclobond ll7ll, and Cyclobond I SN
stationary phases [71]. Additionally, B-cyclodextrin CSPs have been used to separate the
enantiomers of several flavanone glycosides such as prunin, naringin, neohesperidin, and
narirutin [45]. This makes cyclodextrin based CSPs a natural choice for the enantioseparation
of racemic mixtures of chiral dihydrofurocoumarins and dihydrofuroflavones
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Figure 1. a) Psoralen type compounds are "linear" derivatives of coumarin where the furan
ring is fixed to the 6,7-segment of the coumarin. The structure is numbered as the
parent coumarin would be for consistency of comparisons in the discussion. b)
Angelicin type compounds are derivatives of coumarin where the furan ring is
fused to the 7,8-segment of the coumarin. c) A chiral, substituted angelicin











Figure 2. a)Flavone structure. b) Dihydrofuroflavones type compounds are derivatives of
flavones where the furan ring is fused to the 7,8-segment of the flavone. The
structure is numbered as the parent flavone for consistency of comparisons in the
discussion. c) A chiral, substituted dihydrofuroflavone analogue where the
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Abstract
A set of 28 rucemic dihydrofurocoumarins in which the stereogenic center is located
in the furan ring have been synthesized. Currently no effective asymmetric synthesis of this
class of compounds exists, although their enantiomers are produced biologically by certain
plants. Their diverse medicinal properties are being investigated in several laboratories. The
enantioselective separation of these dihydrofurocoumarins by three native and six derivatized
cyclodextrins has been evaluated in the reversed phase mode, the polar organic mode, and
normal phase mode. The hydroxypropyl-B-cyclodextrin is the most effective chiral
stationary phase (CSP) at separating the dihydrofurocoumarins into enantiomers, showing
some enantioselectivity for 22 dihydrofurocoumarins, and baseline resolving 16 of the 28
compounds in the reversed phase mode. The acetyl-B-cyclodextrin and 2,3-dimethyl-B-
cyclodextrin also showed enantioselectivity for a large number (18 and 17 respectively) of
dihydrofurocoumarins in the reversed phase mode. The native cyclodextrins are ineffective
and the aromatic derivatized p-cyclodextrins are only marginally effective at separating the
I Graduate Student and Major Professor, respectively, Department of Chemistry
Iowa State University.
'Primary researcher and author.
3 Author in correspondence.
r6
furocoumarin enantiomers in the reversed phase mode. The polar organic mode and the
normal phase mode have also been evaluated with these CSPs, but no enantioseparations
were observed.
Introduction
Over the last several years, furocoumarins have received considerable attention from
chemists, biologists, and pharmacologists. Two general classes of furocoumarins are the
psoralens and angelicins (Fig. 1). Both of these classes of compounds contain the parent
coumarin structure fused to a dihydrofuran ring. Furocoumarins are found many places in
nature, most often in plants. Different substituted furocoumarins have been found in celery
[1], bark extracts [2], citrus oil [3], and culinary herbs (parsley [4], dill, fennel, and cumin).
Furocoumarins are known to exhibit a variety of biological effects. Most significant
are their photosensitizing and mutagenic activities [5-8]. Ancient Egyptians used psoralens
in the form of plant extracts for the treatment of skin disorders t9]. kt more recent times,
furocoumarins have been used for the treatment of psoriasis and vitiligo (skin de-
pigmentation). Naturally occurring psoralen, bergapten, and xanthotoxin were found to be
most active against skin diseases and were used in PUVA therapy (Psoralen-UltraViolet A).
Upon exposure to long wavelength UV light (320-380 nm) furocoumarins form adducts with
DNA nucleotides [10,11]. These adducts prevent the proliferation of cells from damaged or
diseased tissues by halting DNA replication, which disrupts cellular division. While both
mono- and di-adducts have therapeutic effects, inter-strand cross-linked adducts are primarily
responsible for un-repairable DNA damage and undesired mutagenic effects [6]. More
recently, furocoumarins have been investigated for their ability to inhibit acetylcholinesterase
[12], their cytotoxicity against KB cells 121 @ line of cancerous cells), and for distinguishing
between active and inactive rRNA [13].
It is well know that the biological activity of enantiomeric compounds can vary
greatly. Consequently, it has become standard practice to assess the biological activity of
each enantiomer of a chiral molecule and to produce drugs and food products mainly as
t7
single enantiomers [14]. Only recently has there been any investigation into the biological
activity of chiral dihydrofurocoumarins [2,15]. To date, the development of asymmetric
syntheses of chiral dihydrofurocoumarins has been limited U6,l7l and there have been no
methods published in the literature pertaining to the enantioseparation of chiral
dihydrofurocoumarins. As such, methods must be developed to obtain both enantiomers in
their pure form and to determine the activity of each.
Cyclodextrin based chiral stationary phases (CSPs) have been shown to be broadly
applicable in their ability to separate enantiomers of a wide variety of compounds [18,19].
They are quite successful at resolving the enantiomers of chiral molecules with aromatic
substituents 120-241. Furthermore, it has been shown that cyclodextrins are useful in the
analysis of various coumarin derivatives, as a CSP for the enantioseparation of warfarin,
coumachlor, coumafuryl, phenprocoumon 123,251, and as post column fluorescence
enhancing reagents for psoralen and phenprocoumon125,26l. Consequently, cyclodextrin-
based CSPs are a natural choice as CSPs for addressing the liquid chromatographic chiral
separation of these compounds.
Recent efforts by Rozhkov et. al. l2Tlhave generated chiral dihydrofurocoumarins by
the palladium-catalyzed annulation of l,3-dienes by o-iodo-umbelliferones. Substituents on
the dihydrofuran portion of the heterocycle create a stereogenic center (Fig. 1c). The aim of
this work is to evaluate the enantioselectivity of native and derivatized cyclodextrin based
CSPs for these chiral dihydrofurocoumarins. Both substituted psoralens and substituted
angelicins are examined in different chromatographic modes.
Experimental
Materials
The CSPs were obtained from Advanced Separation Technologies (Whippany, NJ,
USA). All stationary phases used consisted of the chiral selector bonded to 5 pm spherical
silica gel. The chiral selectors used are the underivitizedcyclodextrins and the derivatizedB-
cyclodextrins, which are illustrated in Fig. 2. The dimensions of the columns arc25Ox4.6
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mm. The triethylamine, methanol, acetonitrile,2-propanol, and hexane used were HPLC
grade from Fisher (Fairlawn, NJ, USA). Sodium chloride and acetic acid were ACS certified
grade from Fisher. All substituted dihydrofurocoumarin were prepared as outlined
previously [27].
Equipment
The HPLC system used consisted of a quaternary pump, an auto sampler, a UV VWD
detector (1050, Hewlett Packard, Palo Alto, CA, USA), and an integrator (3395, Hewlett
Packard). Mobile phases were degassed by ultra-sonication under vacuum for 10 minutes.
UV detection was carried out at 220 nm. A11 separations were carried out at room
temperature (-23"C).
Column Evaluation
The performance of each stationary phase was evaluated in the reverse phase mode
using acetonitrile/water and methanol/water mobile phases. The aromatic deivatized CSPs,
Cyclobond DMP, RN, and SN, were also evaluated in the normal phase mode
(isopropanol/hexane) and in the polar organic mode (l00Vo acetonitrile). The composition of
the mobile phase was optimizedfor resolving the enantiomers of each compound at a flow
rate of 1.0 mL min-I.
Calculations
Dead times (ty,a) were estimated using the refractive index solvent peak on each CSP.
Retention factors (k) were calculated using the equation k = (t,- tu)/tru. Enantioselectivity
(of was calculated using the equation q= kz/k. Resolution factors (&) was calculated using
the equation R,=) x(t2 - tJ) / fut t w), where t2 andt,l ue the retention times of the




A series of 28 racemates, including 7 substituted psoralen derivatives, 14 substituted
angelicin derivatives, 5 substituted dihydrofurocoumarins, and 2 substituted coumarins were
evaluated on nine different cyclodextrin based CSPs in the reversed phase mode (see Table I
for structures and separation data). Fig. 3 is a summary of the performance of each CSP in
the reversed phase mode. Clearly the best CSP for these chiral dihydrofurocoumarins utilizes
hydroxypropyl-p-cyclodextrin as the chiral selector (Cyclobond I RSP). The acetyl-B-
cyclodextrin (Cyclobond I AC) and 2,3-dimethyl-B-cyclodextrin (Cyclobond I DM) based
CSPs were also able to resolve a large number of dihydrofurocoumarins. The remaining
CSPs, native cyclodextrins and aromatic derivatized p-cyclodextrin, were either ineffective
or showed enantioselectivity for a small number of the examined dihydrofurocoumarin
compounds in the reversed phase mode. A partial separation of enantiomers is reported in
Fig. 3 if there is an observable enantioselectivity (a> 1.02) and a baseline separation of
enantiomers is reported if the peak-to-peak resolution (R,) exceeds 1.5.
The effect of mobile phase composition was also investigated. All28 compounds
were analyzed in the reversed phase mode with both acetonitrile/water and methanol/water
mobile phases on all CSPs. Generally, comparable results for enantioselectivity and
resolution were obtained with each solvent system; however, there were several cases where
an acetonitrile/water mobile phase successfully separated enantiomers where the
methanoVwater mixture failed. This is thought to be due to hydrogen bonding of the
methanol molecules to the hydroxyl groups on the cyclodextrin, which may interfere with the
enantioselective complexation process. The effect of pH (4.00, 5.00, 6.00, 7.00, and
unbuffered [pH = 6.20),O.lVo (v/v) triethylaminelacetic acid) and ionic strength (0 M,0.10
M, 0.20, 0.30, 0.40, and 0.50 M NaCD were also investigated. However, neither appreciably
affected selectivity or resolution (data not shown). This is due to the fact that the
dihydrofurocoumarins are neutral, hydrophobic compounds with no ionizable groups (see
Fig. 1 and Table t).
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Cyclobond I RSP, AC, and DM Chiral Stationary Phases
Table I summarizes the separation data for the most effective Cyclobond AC, DM,
and RSP columns in the reversed phase mode of operation. The structure of each
dihydrofurocoumarin and the optimal mobile phase compositions are given, as well as the
values for k, Rs, and a.
It is well known that cyclodextrin CSPs excel at enantioseparations where the
analytes contain large aliphatic groups or multiple aromatic ings120-241. For example, the
separation of angelicin derivatives 1,2, and 3 clearly show that an increase in steric bulk
about the stereogenic center improves the separation on all 3 of the non-aromatic derivatized
B-cyclodextrin CSPs (Table D. On the hydroxypropyl-p-cyclodextrin CSP, the resolution of
these compounds is enhanced (see Fig. 4). Compound 14 also shows that an excess of steric
bulk can hinder a separation on some CSPs (Cyclobond I AC and DM) and enhance
selectivity on others (Cyclobond I RSP).
Other examples of the importance of steric interactions near the chiral center are
shown in the separation of compounds 9, 10, and l1 on these CSPs. While these molecules
are structurally similar, the addition or removal of one methyl group alpha to or beta to the
stereogenic center can greatly affect the observed enantioselectivity (see Fig. 5). The methyl
groups create additional steric bulk near the chiral center, which enhances chiral recognition.
Conversely, compounds 6, 8, and 12 have little steric bulk near the chiral center, leading to
diminished enantioselectivity. Therefore, steric bulk must play a significant role in the
selectivity of these types of compounds.
The enantioseparations of the dihydrofuroangelicin derivatives and their
corresponding structural isomers (the dihydrofuropsoralen derivatives) is also of interest.
While these pairs of analytes are quite similar, the more-linear psoralen derivatives are
generally less well resolved than their angelicin derivative counterparts. This is the case for
compounds 8 and 20,9 and24, and 13 and 25. The results for compounds 8 and 2O, and 13
and25 are shown in Fig. 6. The difference in enantioselectivity between
dihydrofuroangelicin derivatives and dihydrofuropsoralen derivatives must be due to the
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spatial orientation of the dihydrofuran Broup, which limits the rotational or reorientational
ability of the analyte in the inclusion complex. It is also if interest to note that, when
comparing dihydrofuroangelicin derivatives with the dihydrofuropsoralen derivative
structural analogs, a separation of enantiomers is not achieved in the case of the
dihydrofuropsoralen analytes. For example, compare compounds 7,8, and 12, which are
dihydrofuroangelicin derivatives, with compounds 21,20, and26 which are the
corresponding dihydrofuropsoralen derivatives (which are not separated into enantiomers).
There is only one case where a dihydropsoralen analogue is better resolved than its
dihydroangelicin counterpart - compounds 6 vs. 22.
It was also observed that the orientation of the dihydrofuran oxygen in relation to the
coumarin affects the enantiomeric separation. For example, compounds 17 and 18 are very
similar in structure, as are compounds 15 and 16. Figure 7 is acomparison of the
enantiomeric separation of compounds 17 and 18 (which differ only in the location of the
oxygen heteroatom in the furan ring) on the Cyclobond I RSP. The best chiral selector for
this class of compounds is the hydroxypropyl-B-cyclodextrin (Cyclobond I RSP), as all four
of these analytes are baseline resolved (Rs > 1.5). Greater selectivity was observed when the
dihydrofuran oxygen was alpha to position 5 on the coumarin for the Cyclobond I RSP
(compounds 16 and 18) and alpha to position 6 for the Cyclobond I AC column (compounds
15 and 17).
Obviously the exact location of the fused dihydrofuran ring (on the parent coumarin)
has a significant impact on the separation. This is further shown by comparing the results
from compounds l, L5,16, and 19 on the Cyclobond I AC and RSP CSPs. The best
orientation for enantioresolution on these CSPs is when the dihydrofuran moiety is fused to
the 5 and 6 positions on the coumarins, as is the case for compounds 15 and 16.
Other CSPs - Native and Aromatic Derivatized Cyclodextrins
Other cyclodextrin-based CSPs were much less effective in separating enantiomers of
these types of compounds in the reversed phase mode. These remaining CSPs can be divided
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into two categories: aromatic derivatized cyclodextrin CSPs (Cyclobond I RN, SN and DMP)
and native cyclodextrin CSPs (Cyclobond I, II, and Itr). The results of these analyses are
presented in Table II. The aromatically derivatized cyclodextrins (Cyclobond I DMP, RN,
and SN) are not as successful for this class of compounds. As only a limited number of
separations were observed with the aromatically derivatizedcyclodextrins, it is reasonable to
conclude that an excess of aromatic steric bulk on the chiral selector is detrimental to the
enantioseparation of most chiral dihydrofurocoumarins. The native cyclodextrins did not
show any selectivity for any of the analytes investigated.
Normal Phase and Polar Organic Modes
The normal phase mode was investigated on all of the aromatically derivatized CSPs.
The Cyclobond I RN, SN, and DMP columns were each evaluated with a 5/95
isopropanol/trexane mobile phase. All analytes were appreciably retained, but no
enantioselectivity was observed. The polar organic mode was also investigated under the
weakest condition (lOOVo acetonitrile) where all compounds eluting at the dead time of the
column.
Mechanistic Observations
The binding of a dihydrofurocoumarin analyte to a cyclodextrin CSP is a dynamic
process. Both the furan portion and the lactone portion of a dihydrofurocoumarin molecule
can enter the cyclodextrin cavity to form an inclusion complex in the reverse phase mode, but
only one of the two inclusion complex orientations will produce the enantioselectivity which
leads to the observed chiral separation. It is well established that, for a cyclodextrin to form
an enantioselective diastereomeric complex, the substituents off of the stereogenic center of
the analyte must be in close proximity to the secondary hydroxyls at the mouth of the
cyclodextrin in order to achieve the necessary three-points of interactionll9,24,28]. If the
furan portion of the molecule resides in the cavity of the cyclodextrin upon inclusion, the
stereogenic center will be buried inside the cyclodextrin torus, not in close proximity to the
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secondary hydroxyl groups (or the derivative groups on these hydroxyls) on the larger rim of
the molecule. In this case, the substituents on or ne.u the analyte's stereogenic center will be
unable to interact with the porton of the chiral selector that is most responsible for chiral
recognition. It is then reasonable to conclude that, for chiral recognition to occur, the lactone
portion of the analyte molecule must occupy the cyclodextrin cavity and the furan portion is
in close proximity to the mouth of the cyclodextrin cavity where the secondary hydroxyls and
their substituents are located.
The size of these analytes (Table I and tr) supports the contention that the same
portion of these polycyclic analytes must protrude from the torus of the cyclodextrin cavity
when an inclusion complex is formed. The hydroxylpropyl-p-cyclodextrin CSP and acetyl-
p-cyclodextrin CSP (Cyclobond I RSP and AC) are very successful at resolving larger
analytes where significant portions of the included molecule protrude from the cyclodextrin
(23,29), whereas native cyclodextrins are not. The hydroxylpropyl and acetyl groups of the
derivatized cyclodextrins are also known to extend beyond the mouth of the cyclodextrin
cavity (28) and are in a position to interact with both the dihydrofuran moiety and any
substituents attached to the stereogenic center. This has previously been shown to be the
most prominent interaction that leads to enantioselectivity in the cases when the
hydroxylpropyl-p-cyclodextrin CSP is superior to the native p-cyclodextrin CSP [29].
Therefore, the additional interactions produced by these derivative groups are essential for
chiral recognition. Taking into consideration the fact that native cyclodextrins CSPs are
completely ineffective in separating these compounds, one must conclude that when the
dihydrofurocoumarins form an enantioselective inclusion complex with a derivatized
cyclodextrin in the reversed phase mode, their stereogenic center be located near the mouth
of the cyclodextrin selector.
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Conclusions
The Cyclobond I AC, DM and RSP are the most effective cyclodextrin-based CSPs
for resolving the enantiomers of chiral dihydrofurocoumarins in the reversed phase mode.
This is due to the analyte complexing with these chiral selectors in such a way that the
substituents off of the dihydrofurocoumarin stereogenic center interact with the derivative
moieties on the cyclodextrin molecule. The presence of steric bulk about the analytes chiral
center greatly enhances the chiral recognition of these enantiomers. The orientation of the
furan oxygen as well as the spatial placement of the dihydrofuran moiety on the parent
coumarin molecule both play a major role in the selectivity of the separation. Generally, the
angelicin-type coumarins are better resolved than their psoralen analogues. The aromatic
derivatized and native cyclodextrins are mostly ineffective at resolving these types of
analytes. The normal phase and polar organic modes could not be used to separate any of
these compounds into their enantiomers with these CSPs.
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f igure 1. a) Psoralen type compounds are "linear" derivatives of coumarin where the furan
ring is fixed to the 6,7-segment of the coumarin. The structure is numbered as the
parent coumarin would be for consistency of comparisons in the discussion. b)
Angelicin type compounds are derivatives of coumarin where the furan ring is
fused to the 7,8-segment of the coumarin. c) A chiral, substituted angelicin
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Figure 2. a) Native alpha, beta, and garnma cyclodextrins (i.e. Cyclobond Itr, I and [I
respectively). b) Types of derivatized cyclodextrins. An asterisk denotes the




























N Baseline Separations I Some Enantioselectivity
Figure 3. Number of separations in the reversed phase mode using cyclodextrin-based
CSPs. The various types of cyclodextrins and their designated abbreviations are
illustrated in Figure l. Grey Bars: number of observable enantioselective
separations, enantioselectivity, &,) L.02. Black Bars: number of baseline





Figure 4. Enantioseparation of Dihydrofurocoumarins l,2, and 3 (in order of elution) on







f igure 5. The effect of steric bulk on the enantioseparations. Separations performed on the
Cyclobond RSP CSP with a 30170 ACN/water mobile phase.









Figure 6. Angelicin/Psoralen analogue enantioseparations. Separations of
dihydrofurocoumarins 13 and 25 performed on the Cyclobond RSP CSP.
Separations of dihydrofurocoumarins 8 and20 performed on the Cyclobond AC
CSP. a) Angelicin analogue 13. b) Psoralen analogue 25.






Figure 7. The effect of the dihydrofuran orientation on the separation of enantiomers on the
Cyclobond RSP CSP. a) Dihydrofurocoumarin 17. b) Dihydrofurocoumarin 18.
34
Table 1. Retention factor (k'), enantioselectivity (a) and enantioresolution (R,) of all
dihydrofurocoumarins on Cyclobond I2000AC, DM, and RSP CSPs
n Mobile phase composition A) 20180 ACN/water B) 30/70 MeOtUwater C) 35165
MeO[Vwater D) 15/85 ACN/water E) 50/50 MeOlVwater F) 50/50 ACN/water
G) 30170 ACN/water H) 55145 MeOlVwater I) 4O160 MeOlVwater l) 25175 ACN/water
K) 45155 MeOlVwater
b Separation of diastereomers
CYclobond AC CyclobondDM RSP
Compouud# Structure k a Rs Mobib Phase o k a Rs MobibPhase' k t Rs MobibPhase'
I $ 332 1.18 1.93 A 5.54 D 3.83 r.2t 1.31 K
2 3.11 1.10 0:77 A 623 t.t4 t.92 D 6.49 t.2t 1.58 K
3 5.28 t.u 2.2t A 438 1.39 4.02 A 12.46 t.2l 1.80 K
5.02 t.w 0.55 A 4.20 A 6.57 1.13 t36 I
9.65 1.18 t:73 B 329 A 23.4 1.13 1.03 D
6 2.?1 A 5.03 1.04 0.n A 11.99 I
7b ,{d" 5.54 C 5.14 1.40 3.31 D 6:70 t.5't 5.67 A
8 P" 4.33 1.t7 t.63 B 4.t3 A 6.99 1.08 0.66 I
9 $ 6.24 1.23 2.t0 C 5:77 A 6.16 1.09 0.il K
10 10.20 r.25 2.62 D 8.38 l.l9 t.43 D 't.26 t.4l 3.20 E
11 6.50 1.16 1.65 D 6.82 t.t7 1.56 D tL34 t.t4 t35 A
t2 4.46 A 15.16 r.05 0.68 A 20:75 1.04 0.30 A




Structure k a Rs MobibPhase o k a Rs MobihPhase' k a Rs Mobile Phase '
t4 6.19 L.t4 0.82 I 6.Ut J 4.67 t.44 3.57 G
15
ah." 2.84 LA3 2.t4 B 238 LA7 037 C 6.44 t.t4 r34 C
L6 abe" 4.49 1.06 0.68 G 6.ffi 1.04 0.48 D 4.53 t.28 2:t3 I
t7 Y.\)Q"" 238 1.10 0.93 G 2.54 1.05 0.44 D 3.88 t.t7 2.1'l I
18 B* 3.20 1.09 0.6t G 5.33 l.l6 1.70 D 5.01 1.31 3.n A
19 "f 3.M 1.05 0.47 I 3.2i A 8.75 1.10 1.78 A
20 218 A 7.42 D 2.25 I
2Lb 2.44 A 5.81 L.t2 1.37 D t.82 I
22 2i5 D 837 t.w 014 D 17.40 1.08 t.26 D
23 4.61 LAl 0.51 D 6.35 LVt 2.42 D 19.38 1.1 1 1.69 D
24 235 A 8.49 1.06 0i6 D 434 r.ut 0.85 A
25 6.80 A 10.25 t.t4 1.16 A 9.63 t.24 2.08 E
26 t:74 I 2:t9 G t9.21 A
27 ,"-Q$.,c 2.12 D 4.51 I 5.03 1.18 r30 C
23 2.09 D t.62 I 2.34 I
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Table 2. Retention factor (k'), enantioselectivity (a), and enantioresolution (Rs) for chiral
dihydrofurocoumarins separated on Cyclobond RN, and DMP CSPs
Gompound # K CT HS Mtopile rnase
10 8.70 1.11 1.34 G
11 4.45 1.05 0.33 B
19 3.84 1.04 o.76 E
20 7.11 1.04 0.32 B
26 4.71 1.32 2.38 A
uompouno # K C[ HS tvto[,ile rrrase
15 4.55 1.05 0.60 D
19 3.41 1.05 0.53 E
u Mobile Phase composition /t)75125 MeOlVwater C) 60140 MeOlUwater
B) 55145 MeOlVwater D) 50/50 MeOlVwater E) 40160 ACN/water
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Abstract
A set of 13 racemic dihydrofuroflavone analytes in which the stereogenic center is
located in the furan ring have been synthesized. Currently no effective asymmetric synthesis
of this class of compounds exists. These compounds have various medicinal properties which
are currently being investigated in several laboratories. The enantioselective separation of
these dihydrofuroflavones by three native and six derivatized cyclodextrins has been
evaluated in the reversed phase mode, the polar organic mode, and normal phase mode.
Overall, 9 of the 13 dihydrofuroflavone analytes were baseline resolved (Rs > 1.5) on at least
one of the cyclodextrin-based chiral stationary phases. The hydroxypropyl-p-cyclodextrin
(Cyclobond I RSP) is the most effective chiral stationary phase (CSP) for the
enantioseparations of these dihydrofurocoumarins analytes. It shows some enantioselectivity
for 11 dihydrofuroflavones, and baseline separates 7 of the 13 compounds in the reversed
phase mode. The 2,3-dimethyl-p-cyclodextrin also performed well, baseline separating 5 of
the 13 analytes in the reversed phase mode.
I Graduate Student and Major Professor, respectively, Department of Chemistry
Iowa State University.
2 Primary researcher and author.
3 Author in correspondence.
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The native cyclodextrins showed no enantioselectivity for this class of compound in
the reversed phase mode. The aromatic derivatized p-cyclodextrins are only marginally
effective at separating the dihydrofuroflavone enantiomers in the reversed phase mode. The
polar organic mode and the normal phase mode have also been evaluated with the native and
aromatic derivatized p-cyclodextrins, but no enantioseparations were observed.
Introduction
In the last decade flavones and flavonoids have been recognized by chemists,
biologists, and pharmacologists as an emerging class of important compounds. Flavones and
flavonoids are produced naturally by many plant species. Different substituted flavones have
been found in red wine, onions, apples, teas, various berries ll-2l,as well as in many tree
barks and leaves l3-7).
Flavones and flavonoids have been shown to exhibit a vast array of beneficial
physiological effects. The most significant of these are their antioxidant poroperties.
Naturally occurring flavonoids such as quercetin, myricetin, and genistein can inhibit the
oxidation of low density lipoproteins by scavenging free radicals [8,13], inhibit the oxidative
damage of DNA [9], and stimulate DNA repair [11]. Other flavonoids have shown the
ability to inhibit tumor growth [10] and inhibit blood platelet function [12]. Various human
studies have shown that a diet rich in flavonoids is beneficial for the prevention and
treatment of a wide variety of chronic diseases ll4-L71.
Recently, Rozhkov et al. have developed a synthesis for chiral dihydrofuroflavones
via the palladium-catalyzed annulation of 1,3-dienes by o-iodoacetoxyflavonoids [18].
Substituents on the dihydrofuran portion of the heterocycle create a stereogenic center in the
ring (Fig. 1c).
It is well know that the biological activity of enantiomeric compounds can vary
greatly. Consequently, it has become standard practice to assess the disposition, function,
and effect of each antipode of a chiral molecule [19]. As a consequence, most new products
are produced and marketed as single isomers [19]. To date, there has been no investigation
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of the biological activity of the individual enantiomers of chiral flavonoids. Also there is no
reported, widely effective synthetic approach for these molecules. As such, methods must be
developed to obtain both enantiomers in their pure form and to determine the activity of each.
Cyclodextrin based chiral stationary phases (CSPs) have been shown to be broadly
applicable in their ability to separate enantiomers of a wide variety of compounds [20,21].
They are quite successful at resolving the enantiomers of chiral molecules with aromatic
substituents or large aliphatic groups 122-261. Furthermore, it has recently been shown that
cyclodextrin-based CSPs are useful in the analysis of various chiral furocoumarin and
dihydrofurocoumarin derivatives (which are a structurally related class of compounds) 127).
Consequently, cyclodextrin-based CSPs are a natural choice as CSPs for addressing the
liquid chromatographic enantiomeric separation of these compounds.
Experimental
Materials
The CSPs (Cyclobond I, Cyclobond I AC, Cyclobond I DM, Cyclobond I DMP,
Cyclobond I RN, Cyclobond I SN, Cyclobond I RSP, Cyclobond II, and Cyclobond III) were
obtained from Advanced Separation Technologies (Whippany, NJ, USA). All stationary
phases used consisted of the chiral selector bonded to 5 pm spherical silica gel. The chiral
selectors used are underivitized cyclodextrins and the derivatized B-cyclodextrins, illustrated
in Fig. 2. The dimensions of the columns are25O x 4.6 mm. i.d. The triethylamine,
methanol, acetonitrile, 2-propanol, and hexane were of HPLC grade and obtained from
Fisher (Fairlawn, NJ, USA). Sodium chloride and acetic acid were ACS certified grade from
Fisher. All substituted dihydrofuroflavones were prepared as previously reported [18].
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Equipment
The HPLC system used consisted of a quaternary pump, an auto sampler, a UV
variable wavelength detector (1050, Hewlett Packard, Palo Alto, CA, USA), and an
integrator (3395, Hewlett Packard). Mobile phases were degassed by ultra-sonication under
vacuum for 10 minutes. UV detection was carried out at 220 nm. All separations were
carried out at room temperature (-23"C).
Column Evaluation
The performance of each stationary phase was evaluated and optimized in the reverse
phase mode using acetonitrile/water and methanol/water mobile phases. The aromatic
derivatized CSPs, Cyclobond DMP, RN, and SN, were also evaluated in the normal phase
mode (isopropanol/trexane) and in the polar organic mode (lOOVo acetonitrile). The
composition of the mobile phase was optimizedfor each pair of enantiomers and at a flow
rate of 1.0 mL min-I.
Calculations
Dead times (r1y) were estimated using the refractive index solvent peak on each CSP.
Retention factors (k) were calculated using the equationk = (tr- til/tu where r. is the
retention time of the analyte andtu is the dead time of the column. Enantioselectivity (a) was
calculated using the equatiol a= kz/h where k1 andkz are the retention factors of the first
and second eluting enantiomers. Resolution factors (&) were calculated using the equation
Rr=2 x (tQ - trl ) / (w t + w), wherc tQ and trl ue the retention times of the second and first
enantiomers respectively and wl undvtz ?ta the base peak widths of the corresponding peaks.
4l
Results and Discussion
A series of 13 racemates were evaluated on nine different cyclodextrin based CSPs in
the reversed phase mode (see Table I for structures and separation data). Figure 3 is a
summary of the performance of each CSP in the reversed phase mode. Clearly the best CSP
for these chiral dihydrofuroflavones utilized hydroxypropyl-p-cyclodextrin as the chiral
selector (Cyclobond I RSP). The 2,3-dimethyl-p-cyclodextrin (Cyclobond I DM) based
CSPs was also able to separate a large number of dihydrofuroflavones. The remaining CSPs,
native cyclodextrins and aromatic derivatized B-cyclodextrin, were either ineffective or
showed enantioselectivity only for a small number of the examined dihydrofuroflavone
compounds in the reversed phase mode. A partial separation of enantiomers is reported in
Fig. 3 if there is an observable enantioselectivity (a> 1.02) and a baseline separation of
enantiomers is reported if the peak-to-peak resolution (Rr) exceeds 1.5.
The effect of mobile phase composition was also investigated. All 13 compounds
were analyzed in the reversed phase mode with both acetonitrile/water and methanoUwater
mobile phases on all CSPs. Generally, comparable results for enantioselectivity and
resolution were obtained with each solvent system; however, there were several cases where
an acetonitrile/water mobile phase successfully separated enantiomers where the
methanoUwater mixture failed. This is thought to be due to hydrogen bonding of the
methanol molecules to the hydroxyl groups on the cyclodextrin, which may interfere with the
enantioselective association process. The opposite effect was observed for the aromatic
derivatized cyclodextrin CSPs as methanoUwater mobile phases were more useful at
separating the enantiomers of chiral dihydrofuroflavones than the acetonitrile/water mobile
phases (Table II). The effect of pH (4.00, 5.00, 6.00, 7.00, and unbuffered [pH = 6.20l,0.l%o
(v/v) ffiethylamine/acetic acid) and ionic strength (0 M, 0.10 M, 0.20, 0.30, 0.40, and 0.50 M
NaCl) were also investigated. However, these type of mobile phase modifications did not
affect the selectivity or resolution (data not shown). This result is likely due to the fact that
the dihydrofuroflavones are neutral, hydrophobic compounds with no ionizable groups (see
Fig. 1 and Table I).
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Cyclobond I RSP and DM Chiral Stationary Phases
Table I summarizes the separation data for the Cyclobond I DM and Cyclobond I
RSP columns in the reversed phase mode of operation. The structure of each
dihydrofuroflavone and the optimal mobile phase compositions are given, as well as the
values for k, Rs, and a.
It is well known that cyclodextrin CSPs excel at enantioseparations where analytes
have bulky groups near the stereogenic center 122-261. For example, the separation of
analyes 1,2, and 3 clearly shows that changing the local environment near the stereogenic
center effects the separation on both of the non-aromatic derivatized p-cyclodextrin CSPs
(Table I). The resolution of these compounds on the hydroxypropyl-p-cyclodextrin CSP is
decreased with the addition/removal of a single methyl- group (Fig. a). This is supported by
the separations of compounds I and 2. It is also of interest to note that the removal of a
methyl group beta to the chiral center is detrimental to the observed separation (compounds 2
and 3).
The trends on the 2,3-dimethyl-p-cyclodextrin (Cyclobond I DM) are quite different
from those on the hydroxypropyl p-cyclodextrin (Cyclobond I RSP). For example, a
comparison of the separations of compounds I and 2 show that the addition of a methyl
group on the chiral center greatly enhances chiral recognition and enantioresolution. It is also
seen that the removal of a methyl- group beta to the stereogenic center is slightly detrimental
to the observed separation as shown by the data from compounds 2 and 3 (Fig. 5).
In all cases, these methyl groups create an additional steric interaction near the
stereogenic center which can greatly affect chiral recognition. Other examples of this
interaction are shown in the separation of compounds 8 and 11. These compounds have a
large amount of steric bulk near the chiral centers which is known to enhance chiral
recognition. These same groups are also quite rigid which eliminates the rotational
movement of the goups about the stereogenic center which is also beneficial to chiral
recognition [21]. Conversely, compounds 5 and 10 have little steric bulk near the chiral
center and a high degree of rotational mobility leading to diminished chiral selectivity and
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enantioresolution. Therefore, steric interactions and molecular rigidity must play a significant
role in the selectivity of this class of compounds.
The enantioseparations of the structural isomers of the dihydrofuroflavones are also
of interest. While these analytes are quite similar, the more linear dihydrofuroflavone
derivatives in which the furan moiety is attached at the 6,7 position are generally much less
well resolved than their more angular structural isomers (attached at the 8,9 position). This is
shown in Fig. 6 for compounds 11 and l2.The more angular dihydrofuroflavone
(compounds 11) is more easily separated into its enantiomers on each stationary phase. This
same trend is shown when comparing the separation of compounds 4 and 13. The difference
in the observed enantioselectivity between these groups of compounds must be due to the
spatial orientation of the dihydrofuran group. This limits the orientational or reorientational
ability of the analyte in the inclusion complex as well as giving another point of steric
interaction between the molecule and the substituents on the mouth of the cyclodextrin
cavity.
Other CSPs - Native and Aromatic Derivatized Cyclodextrins
Other cyclodextrin-based CSPs were less useful in separating enantiomers of these
types of compounds in the reversed phase mode. The remaining CSPs can be divided into
aromatic derivatized cyclodextrin CSPs (Cyclobond I RN, SN and DMP) and native
cyclodextrin CSPs (Cyclobond I, II, and Itr). The results of these analyses are presented in
Table tr. The aromatic derivatized cyclodextrins gave the best separation of any of the
analytes investigated (compound l0). This is due to the phenyl- substituent on the
stereogenic center competing as an alternate site for inclusion complexation. As other
analyses with the aromatic derivatized cyclodextrins were less successful, it is reasonable to
conclude that an excess of aromatic steric bulk on the chiral selector is detrimental to the
enantioseparation of most chiral dihydrofuroflavones. The native cyclodextrins did not show
any selectivity for any of the analytes investigated.
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Normal Phase and Polar Organic Modes
The normal phase mode was investigated on all aromatically deivatized CSPs. The
Cyclobond I RN, SN, and DMP columns were each evaluated with a 5/95
isopropanol/hexane mobile phase. All analytes were appreciably retained, but no
enantioselectivity was observed. The polar organic mode was also investigated under the
weakest condition (l0OVo acetonitrile) where all compounds eluted at the dead time of the
column.
Mechanistic Observations
The binding of a dihydrofuroflavone molecule to a cyclodextrin CSP is a dynamic
process. Both the furan portion and the flavone portion of a dihydrofuroflavone molecule
compete to enter the cyclodextrin cavity and form an inclusion complex in the reverse phase
mode. However, only one of these two inclusion complex orientations will produce the
enantioselectivity which leads to an enantiomeric separation. It is well established that, for a
cyclodextrin to form an enantioselective diastereomeric complex, the substituents off of the
stereogenic center of the analyte must be in close proximity to the secondary hydroxyls at the
mouth of the cyclodextrin (in the case of the native cyclodextrins) or be able to interact with
the pendant groups on the derivatized cyclodextrin in order to achieve the necessary three-
points of interactionl2l,26,28l. If the furan portion of the molecule complexes within the
cavity of the cyclodextrin, the stereogenic center will be buried inside the cyclodextrin torus.
This arrangement will not be conducive to chiral recognition as the substituents on the chiral
center will be unable to interact with these hydroxyls (or derivative groups) on the mouth of
the cyclodextrin cavity. Therefore, for chiral recognition to occur, the flavone portion of the
analyte molecule must occupy the cyclodextrin cavity thereby allowing the furan portion
which contains the stereogenic center to be in close proximity to the mouth of the
cyclodextrin cavity where it can interact with the secondary hydroxyls or derivative afins on
the torus of the cavity.
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The size of these analytes (Table I and tr) supports the contention that the same
portion of these polycyclic analytes must protrude above the cyclodextrin cavity when an
inclusion complex is formed. The hydroxypropyl-p-cyclodextrin CSP (Cyclobond I RSP) is
very successful at resolving larger analytes where significant portions of the included
molecule protrude from the mouth of the cyclodextrinl25,29l, whereas native cyclodextrins
are not. The hydroxypropyl groups of the derivatized cyclodextrins are also known to extend
well beyond the mouth of the cyclodextrin cavity [28] and are in a position to interact with
both the dihydrofuran moiety and any substituents attached to the stereogenic center via
steric interactions or hydrogen bonding. These interactions have previously been shown to
be the most prominent interactions that lead to enantioselectivity in the cases where the
hydroxypropyl-B-cyclodextrin CSP is superior to the native B-cyclodextrin CSP [29].
Therefore, the additional interactions produced by these derivative groups are essential for
chiral recognition. Taking into consideration the fact that native cyclodextrins CSPs are
completely ineffective in separating these compounds, one must conclude that when the
dihydrofuroflavones form an enantioselective inclusion complex with a derivatized
cyclodextrin in the reversed phase mode, the stereogenic center must be in close proximity to
the mouth of the cyclodextrin selector.
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Conclusions
The Cyclobond DM and RSP are the most effective cyclodextrin-based CSPs for
separating the enantiomers of chiral dihydrofuroflavones. This selectivity arises from the
ability of the substituent groups at the mouth of the cyclodextrin cavity to interact with the
substituent groups attached to the stereogenic center of analyte molecule. The effect of steric
bulk near the chiral center and the rigidity of the molecule both have a pronounced effect on
enantioselectivity. The spatial placement of the furan moiety about the parent flavone
molecule also has a significant impact on the separation achieved. Generally, the more
angular type flavones are better resolved into enantiomers than the more linear structural
isomers. The aromatic derivatized and native cyclodextrins produced the best separation of
any analyte in this study, but no other baseline enantioseparations were seen on these CSPs.
The normal phase and polar organic modes of operation did not resolve any of these
compounds into enantiomers with the CSPs investigated.
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f igure 1. a) Flavone structure. b) Dihydrofuroflavones type compounds are derivatives of
flavones where the furan ring is fused to the 7,8-segment of the flavone. The
structure is numbered as the parent flavone for consistency of comparisons in the
discussion. c) A chiral, substituted dihydrofuroflavone analogue where the
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f igure 2. a) Native alpha, beta, and gamma cyclodextrins (i.e. Cyclobond Itr, I and II
respectively). b) Types of derivatized cyclodextrins. An asterisk denotes the
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RNYSN
r Baseline @ Some Selectivity
Figure 3. Number of separations in the reversed phase mode using cyclodextrin-based
CSPs. The various types of cyclodextrins and their designated abbreviations are
illustrated in Figure 1. Grey Bars: number of observable enantioselective
separations, enantioselectivity, aZ 1.02. Black Bars: number of baseline






Figure 4. The effect of steric interactions. Separations performed on the Cyclobond RSP
CSP with a45155 MeOlVwater mobile phase. a) Dihydrofuroflavone 1. b)






f igure 5. The effect of steric interactions. Separations performed on the Cyclobond DM
CSP with a35165 MeOlVwater mobile phase. a) Dihydrofuroflavone 1.





Figure 6. The effect of furan orientation. Separations performed on the Cyclobond RSP
CSP with 15/85 ACN/water mobile phase in case a and 20180 ACN/water mobile
phase in case b. a) Dihydrofuroflavone 11. b) Dihydrofuroflavone 12.
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Table 1. Retention factor (k'), enantioselectivity (a) and enantioresolution (&) of all
dihydrofurocoumarins on Cyclobond I2000 DM and RSP CSPs,
Compound# Structuro k ct Rs Mot{le Phase a k ct Rs Mobrile Phase'
1 3.79 1.30 1.78 3.10
3.10 1.19 1.69 B 3.36 1.25 2.15 D
3 2.62 t.1t 1.00 B 2.O3 1.21 1.99
4 2.46 1.08 0.67 B 7.03 1.06 0.71
2.33 B 2.34 1.05 1.O2 A
o 2.61 B 6.40 1.15 1.83
7 3.40 1. I I 0.73 E 3.83 1.20 2.21 A
I 2.76 1.21 1.50 A 2.12 t.3t 2.25 F
I 3.21 1.63 3.44 B 3.26 1.66 4.00 D
10 5.59 t.t0 1.03 D 7. I I A
11 4.62 1.19 1.64 c 4.86 1.13 1.59 B
12 3.26 B 12.7e 1.14 1.29 F
13 3.13 B 7.84 1.05 0.71 A
u Mobile phase composition /t) 25175 ACN/water B) 20180 ACN/water C) 15/85 ACN/water
D) 45155 MeO[VwaterE) 40160 MeO[I/water F) 35/65 MeOlVwater
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Table 2. Retention factor (k'), enantioselectivity (a), and enantioresolution (Rs) for chiral
dihydrofurocoumarins separated on Cyclobond RN, SN, and DMP CSPs
Compound # K cr HS MODlle rnase
4 12.19 1.09 1.20 D
10 6.21 1.37 4.27 A
Compound # K O[ HS Moplle rnase
6 5.72 1.03 0.58 D
7 4.22 1.O2 o.25 F
I 3.99 1.O2 0.30 F
10 6.78 1.12 1.82 B
11 1.87 1.03 0.53 ts
12 4.50 1.02 0.41 F
Compound # K C[ HS MOpile rnase-
4 9.62 1.06 1.11 E
I 9.51 1.O7 1.38 E
10 10.91 1.46 5.1 3 c
11 7.43 1 .06 1.11 E
12 9.64 1.O2 o.44 G
u Mobile Phase composition lr^)75125 MeOlVwaterB)70130 MeOlUwater C) 65135




Cyclodextrin based CSPs are useful for the enantioseparation of chiral
dihydrofurocoumarins and chiral dihydrofuroflavones. The most effective cyclodextrin based
CSPs for these separations in the reversed phase mode are the acetyl-p-cyclodextrin
(Cyclobond I AC), the 2,3-dimethyl-B-cyclodextrin (Cyclobond I DM), and the
hydroxypropyl-B-cyclodextrin (Cyclobond I RSP).
The observed selectivity is mainly due to the orientation of the analyte-cyclodextrin
complex. The analyte molecules must complex with these chiral selectors in such a way that
the substituents off of the center located in the furan ring can interact with the derivative
moieties on the cyclodextrin molecule. This conjecture is supported by the fact that the native
cyclodextrin CSPs were unable to separate any of the compounds examined. Additionally,
these types of molecules can bind into the cyclodextrin cavity at either the furan end or the
lactone end of the. Both of these orientations contribute to the retention of the analyte,
however, only the complexation of the lactone end of the molecule into the cyclodextrin
cavity will give rise to the correct orientation for the substituents on the chiral center and the
derivative arms on the cyclodextrin to interact. In a small number of cases, the linear
derivatives of the dihydrofuroflavones and dihydrofurocoumarins (psoralens) are also
resolved to a diminished extent. This result is again due to the interaction between the
analyte molecules and the derivative moieties on the cyclodextrin, however, these types of
molecules are more conformationally mobile inside of the cyclodextrin cavity. This
contributes to fewer of this type of analyte being baseline resolved on these CSPs.
Several other interactions also have a pronounced effect on the observed selectivity.
The presence of steric bulk and the rigidity of the substituents about the chiral center have
been shown to greatly enhance the chiral recognition of these analytes. Additionally, the
orientation of the furan oxygen and the spatial placement of the dihydrofuran moiety about
the parent coumarin or flavone molecule both play a significant role in the selectivity of the
separation.
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All of these factors taken together support the accepted mechanism of chiral
recognition on cyclodextrin based CSPs. In the reversed phase mode of operation, more
angular dihydrofurocoumarins (angelicins) and dihydrofuroflavones were better resolved into
enantiomers than their more linear counterparts. This supports the contention that these
molecules must include into the cyclodextrin cavity in an orientation such that the
substituents on the chiral center can interact with the hydroxyl groups or derivative aflns on
the mouth of the cyclodextrin cavity [1]. Since the native p-cyclodextrin did not resolve the
enantiomers of any of the compounds investigated; one must logically conclude that the
interaction with these derivative groups is necessary for the chiral recognition for these
analytes.
No separations for either dihydrofurocoumarins or dihydrofuroflavones were seen in
the polar organic mode of operation. Since neither type of molecule has good hydrogen
bonding $oups near the chiral center, it makes good sense that these molecules would not be
resolved in this mode [2].
Finally, no separations were seen for any of the molecules investigated in the normal
phase mode of operation. Both of these classes of molecule contain an aromatic group which
is a necessary structural feature for molecules to be separated in this mode by these CSPs,
however, it is possible that this interaction does not give rise to the required three points of
interaction about the chiral center [3].
In closing, cyclodextrin based CSPs are quite applicable to the enantioseparation of
racemic mixtures of chiral dihydrofurocoumarins and chiral dihydrofuroflavones. This
method can be used for a preparative separation of the enantiomers of these compounds,
which will allow for the assessment of their individual biological activities. If any of the
enantiomers of these compounds show promising medicinal effects, this analytical approach
could be used for the development of new drugs for the treatment of various diseases.
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